Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma
Articolo
Data di Pubblicazione:
2021
Abstract:
Current first line treatment options in patients with metastatic urothelial carcinoma unfit to receive cisplatin containing chemotherapy include PD-1/L1 inhibitors and carboplatin containing chemotherapy. However, the optimal sequencing of these therapies remains unclear.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
carboplatin; carcinoma; programmed cell death 1 receptor; transitional cell; urinary bladder neoplasms
Elenco autori:
Wei, Xiao X; Werner, Lillian; Teo, Min Y; Rosenberg, Jonathan E; Koshkin, Vadim S; Grivas, Petros; Szabados, Bernadett; Morrison, Laura; Powles, Thomas; Carril-Ajuria, Lucia; Castellano, Daniel; Velho, Pedro Isaacsson; Hahn, Noah M; Mckay, Rana R; Raggi, Daniele; Necchi, Andrea; Kanesvaran, Ravindran; Alerasool, Parissa; Gaines, Jacob; Galsky, Matthew; Bellmunt, Joaquim; Sonpavde, Guru
Link alla scheda completa:
Pubblicato in: